AI Agent 推动 CPU 重定价，关注 Infra 与应用层变化 20260126 摘要 互联网大厂广告代理商链条（如省广、蓝标等）有望受益于大模型产品 广告份额增长，成为关注焦点。同时，AI 应用泛化领域如博纳影业、昆 仑万维等也值得关注。 恒生科技板块中，消费互联网（阿里巴巴、京东健康、贝壳）、算力 （中芯国际、华虹半导体）、软件应用（快手、金蝶、哔哩哔哩）、智 能驾驶（小马智行、文远知行、小鹏汽车）及游戏（三七互娱、腾讯、 心动公司）等子板块均存在投资机会。 存储行业正经历技术升级周期，NAND 和 DRAM 合约价格均超预期上涨， 一季度涨幅分别达到 100%以上和 70%。存储需求显著增加，而供给侧 相对刚性，预计未来 NAND 价格仍有超预期上涨可能。 存储行业投资机会集中在下游存储涨价、上游成本相对稳定的设计公司 （如军政、兆易创新），含存量高的设备公司（如中微公司、拓荆科 技），以及受益于存储涨价周期的模组公司。 Q&A 目前对 A 股传媒板块的看法是什么？ 目前我们认为 A 股传媒板块的 AI 应用行情并未结束，产业趋势强劲支撑这一结 果。尽管近期有所调整，但整体行情的确定性依然较强。 ...

来源：雷递 雷递网 雷建平 1月26日 京东产发在2023年3月已递交招股书，中间上市一度暂停，这是时隔近3年后重启上市。 当下，京东集团旗下有多家上市企业，包括京东集团、京东健康、京东物流、京东工业。 其中，2025年12月，京东工业刚刚在港交所上市，发行价为14.1港元，全球发售2.11亿股，扣非发行应 付上市费用1.51亿港元，募资净额为28.27亿港元。一旦京东产发在港股上市，刘强东旗下将再多一家上 市企业。 9个月营收30亿 亏1.6亿 京东产发是一家现代化基础设施开发与管理平台，通过投资开发、资产管理和多元化增值服务，为全行 业提供现代化标准仓库、一体化智能产业园、数据中心、光伏新能源等基础设施建设与运营的综合解决 方案。 此外，通过为客户提供定制化、全面且智能的基础设施解决方案，以及现代化基础设施网络与端到端的 全域服务能力，京东产发服务的客户逐步从物流服务商延伸到宝马等制造商、本来生活等电商、良品铺 子、永辉超市等零售商，实现服务行业的多元化覆盖。 截至2025年9月30日，京东产发资产管理规模总额为1，215亿元，其中12.8%位于境外；京东产发的总 建筑面积为2710万平方米。 截至202 ...

Group 1 - The core focus of the article is on the performance and strategic adjustments of funds managed by Zhang Kun of E Fund, highlighting the significant differentiation in fund performance and his outlook on domestic consumption and investment opportunities [1][2][3] Group 2 - In Q4 2025, Zhang Kun's managed fund size decreased to 48.3 billion yuan, with a quarterly reduction exceeding 8 billion yuan [2][3] - The largest fund, E Fund Blue Chip Selection Mixed Fund (005827.OF), experienced a nearly 9% loss in Q4, underperforming its benchmark by over 6%, while the E Fund Asia Select Stock Fund (118001.OF) achieved a 4.5% positive return, outperforming its benchmark by over 2% and recording a nearly 42% increase for the entire year [2][3][4] Group 3 - Zhang Kun continued to reduce holdings in the liquor sector, albeit at a slower pace compared to Q3 2025, maintaining a near 10% position in leading liquor stocks like Kweichow Moutai and Wuliangye [4][5][6] - Significant reductions were also noted in pharmaceutical and media stocks, with JD Health seeing a cut of about half in holdings, alongside Tencent Holdings and Focus Media [5][6][7] Group 4 - In overseas investments, Samsung Electronics replaced Tencent Holdings as the top holding in the E Fund Asia Select, with Zhang Kun opting to take profits as stock prices surged [6][7][8] Group 5 - Zhang Kun expressed a strong belief in the future of domestic consumption, arguing that current consumer weakness is not a permanent state and will improve, supported by government goals for income growth and stabilization of housing prices [8][9][10] - He emphasized that a robust domestic consumption market is crucial for technological innovation, suggesting that increased consumer spending will benefit domestic AI companies and accelerate their development [10][11][12] - Zhang Kun remains optimistic about the long-term potential of Chinese consumption and economic growth, viewing current market valuations of quality companies as attractive for long-term investors [10][11][12]

Market Overview - The three major stock indices in A-shares opened higher, with the Shanghai Composite Index rising by 0.21%, the Shenzhen Component Index increasing by 0.37%, and the ChiNext Index up by 0.48% [1] - The STAR Market Index saw a slight increase of 0.04% [1] Sector Performance - The photovoltaic industry chain showed strong performance, particularly the space photovoltaic concept stocks, which led the gains [1] - Notable stocks such as Mingyang Smart Energy, Tuori New Energy, GCL-Poly Energy, Junda Co., and Shuangliang Eco-Energy hit the daily limit up, while stocks like Dongfang Risen, Optec, Aotwei, and Liancheng CNC opened over 10% higher [2] Hong Kong Market - The Hang Seng Index opened up by 0.35%, while the Hang Seng Tech Index saw a minor increase of 0.05% [3] - Stocks such as Pop Mart and Zijin Mining experienced significant gains, with Pop Mart rising over 4% and Zijin Mining nearly 3% [3]

Group 1 - The Hang Seng Index opened up by 0.35% and the Hang Seng Tech Index increased by 0.05% [1] - Pop Mart surged over 4%, while Zijin Mining rose nearly 3% [1] - Tencent Music and JD Health also showed significant gains [1] Group 2 - Baidu Group, Xpeng Motors, and NIO experienced notable declines [1]

Market Overview - The three major stock indices in A-shares opened higher, with the Shanghai Composite Index up by 0.21%, the Shenzhen Component Index up by 0.37%, and the ChiNext Index up by 0.48% [3][4] - The STAR Market Index saw a slight increase of 0.04% [3][4] Sector Performance - The photovoltaic industry chain showed strong performance, particularly the space photovoltaic concept stocks, which led the gains [3][4] - Notable stocks that hit the daily limit include Mingyang Smart Energy, Tuori New Energy, GCL-Poly Energy, JunDa Co., and Shuangliang Eco-Energy [4] - Other active sectors included gold, lithium mining, humanoid robots, and AI applications, while the commercial aerospace concept stocks experienced a slight pullback [3] Hong Kong Market - The Hang Seng Index opened up by 0.35%, and the Hang Seng Tech Index increased by 0.05% [5][6] - Noteworthy gainers included Pop Mart, which rose over 4%, and Zijin Mining, which increased nearly 3% [5]

A股三大股指集体高开，光伏产业链再度走强，太空光伏概念股领涨，贵金属及大宗商品价格大幅攀 升，黄金刷新历史新高。 09:25 A股开盘丨三大股指集体高开 光伏产业链再度走强 三大股指集体高开，沪指涨0.21%，深成指涨0.37%，创业板指涨0.48%。科创综指涨0.04%。光伏产业 链再度走强，太空光伏概念股领涨；黄金、锂矿、人形机器人、AI应用题材活跃。商业航天概念股局 部回调。 太空光伏概念继续大幅高开，明阳智能、拓日新能、协鑫集成、钧达股份、双良节能封涨停，东方日 升、欧普泰、奥特维、连城数控高开超10%。 9:21 港股开盘｜恒指高开0.35% 恒生指数高开0.35%，恒生科技指数涨0.05%。泡泡玛特涨逾4%，紫金矿业涨近3%，腾讯音乐、京东健 康涨幅靠前；百度集团、小鹏汽车、蔚来跌幅靠前。 8:41 现货黄金涨幅扩大1.2%，刷新历史新高至5050美元/盎司，本月累涨730美元。 8:40 现货铂金首次站上2800美元/盎司，今年首月累涨约37%。 7:01 现货黄金首次突破5000美元/盎司，日内涨0.5%。现货白银盘初再创新高，报104.76美元/盎司，涨 幅超1%。 | 名称 | 现价 | ...

Group 1 - The top short-selling ratios are led by AIA Group (81299) and JD Health (86618) at 100.00%, followed by Baidu Group (89888) at 95.46% [1][2] - The highest short-selling amounts are recorded for Pop Mart (09992) at 1.3 billion, Alibaba (09988) at 1.26 billion, and Xiaomi Group (01810) at 1.064 billion [1][2] - The highest deviation values are for Baidu Group (89888) at 62.11%, Shenzhen Expressway (00548) at 37.02%, and SenseTime (80020) at 34.65% [1][2] Group 2 - The top ten short-selling ratios include AIA Group (81299) at 100.00%, JD Health (86618) at 100.00%, and Baidu Group (89888) at 95.46% [2] - The top ten short-selling amounts show Pop Mart (09992) leading with 1.3 billion, followed by Alibaba (09988) with 1.26 billion, and Xiaomi Group (01810) with 1.064 billion [2] - The top ten deviation values highlight Baidu Group (89888) at 62.11%, Shenzhen Expressway (00548) at 37.02%, and SenseTime (80020) at 34.65% [2]

Group 1 - Since September 2024, the proportion of southbound capital transactions has rapidly increased to 20%-30%, nearly doubling compared to before 2024 [2][5] - In 2025, both active and passive foreign capital have become synchronous indicators of the Hong Kong stock market, showing no leading characteristics [2][5] - During sharp declines or corrections in the Hong Kong stock market, southbound capital tends to buy against the trend [2][5] Group 2 - Each round of pricing power competition typically begins with the optimization of the Stock Connect policy or the influx of incremental capital, which usually flows into dividend and scarce assets [5] - Net outflows of southbound capital often occur in response to adverse industry policies or external macroeconomic environments, particularly in sectors where foreign capital pricing power is increasing, such as software services, hardware equipment, consumer services, and discretionary retail [5][12] - Industries less likely to experience significant net outflows include those favored by long-term capital, such as banking, telecommunications, and public utilities, unless there are clear adverse policies affecting the sector [5][12] Group 3 - The proportion of medium to long-term capital in the current round of southbound capital inflow into Hong Kong stocks has increased, with insurance capital making 41 stakes, 35 of which are in H-shares, marking the highest record in the past decade [8] - Key industries for increased holdings include discretionary retail, finance (banking, insurance), innovative pharmaceuticals, software services, and hardware equipment [8] Group 4 - Current industries with pricing power for southbound capital and Chinese capital include semiconductors and dividend stocks, while industries lacking pricing power include internet, hardware equipment, software services, home appliances, and media [11][12] - Active management public funds have low pricing power in the Hong Kong stock market, focusing heavily on AI-related CSP giants, electronics, and innovative pharmaceuticals [16]

Investment Rating - The report maintains a positive investment rating for the pharmaceutical sector [5] Core Views - The report emphasizes three main investment themes for 2026: innovation, overseas expansion, and turnaround impulses, with a focus on BD2.0, small nucleic acids, and supply chain (CXO and upstream) [2][3] - The report suggests that the pharmaceutical sector is currently experiencing a rotation in investment focus, particularly in areas such as brain-computer interfaces, AI integration, small nucleic acids, and medical robotics [3] Summary by Sections Public Fund Holdings Update for Q4 2025 - Overall, the market value of public funds holding pharmaceutical stocks has decreased, with a total market value of 217.6 billion yuan, down by 51 billion yuan from the previous quarter [14] - The pharmaceutical sector's allocation in public funds is 7.96%, a decrease of 1.74 percentage points [19] - Chemical preparations remain the most heavily weighted sub-industry, while allocations to medical devices have increased [14][25] Market Review and Analysis - The pharmaceutical and biotechnology index decreased by 0.39% week-on-week, outperforming the CSI 300 index but underperforming the ChiNext index [1] - The total trading volume in the pharmaceutical sector was 554.24 billion yuan, accounting for 4.00% of the total trading volume in the Shanghai and Shenzhen markets [1] Investment Opportunities - The report identifies specific companies for potential investment, including: - CXO and innovative drug companies such as Tigermed, Zhaoyan New Drug, and Hai Si Ke, which have seen significant increases in fund holdings [16][38] - AI innovative drug companies like Jingtai Holdings and small nucleic acid firms such as Frontier Biotech and Yuyuan Pharmaceutical [3][38] - The report also highlights the importance of exploring CROs, essential drugs, and companies showing signs of bottoming out [3]